Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England
详细信息 查看全文
- 作者：Sonia Saxenaa ; s.saxena@imperial.ac.uk" class="auth_mail" title="E-mail the corresponding author ; Christina Atchisona ; Elizabeth Cecila ; Mike Sharlandb ; Elizabeth Koshya ; Alex Bottlea
- 关键词：Children ; Pneumonia ; Pneumococcal disease ; Empyema ; Vaccination
- 刊名：Journal of Infection
- 出版年：2015
- 出版时间：October 2015
- 年：2015
- 卷：71
- 期：4
- 页码：428-436
- 全文大小：468 K
文摘
- •
In April 2010 in the United Kingdom (UK) a thirteen valent pneumococcal vaccine (PCV13) replaced the seven-valent one (PCV7).
- •
We examined PCV13 impact on childhood pneumonia and empyema admissions.
- •
We found an added benefit of PCV13 over PCV7 on empyema but not pneumonia admissions in infants.